Laboratorio Reig Jofre, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 29, 2021 at 08:08 am EDT
Share
Laboratorio Reig Jofre, S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was EUR 62.060 million compared to EUR 62.115 million a year ago. Operating income was EUR 4.027 million compared to EUR 4.501 million a year ago. Net income was EUR 3.287 million compared to EUR 3.658 million a year ago.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
LABORATORIO REIG JOFRE, S.A. 
